Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver

Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver - Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039146

Enrollment

Registered

2020-01-16

Start date

2020-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary biliary cholangitis or fatty liver

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with PBC or NAFLD who have constipation

Exclusion criteria

Exclusion criteria: 1. patients who are suspected to have ileus. 2. patients with severe CKD. 3, patients with severe liver dysfunction (C-P: B or C). 4. Patients with uncontrolled malignancy.

Design outcomes

Primary

Measure	Time frame
serum ALP levels in 12 months in PBC patients serum ALT levels in 12 months in FL patients	—

Countries

Japan

Contacts

Public ContactTatehiro Kagawa

Tokai University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine,

kagawa@tokai.ac.jp81-463-93-1121

Outcome results